Rockwell Medical (FRA:RWMA) Debt-to-Equity : 0.69 (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Rockwell Medical Debt-to-Equity?

Rockwell Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.87 Mil. Rockwell Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €11.18 Mil. Rockwell Medical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €18.99 Mil. Rockwell Medical's debt to equity for the quarter that ended in Mar. 2024 was 0.69.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Rockwell Medical's Debt-to-Equity or its related term are showing as below:

FRA:RWMA' s Debt-to-Equity Range Over the Past 10 Years
Min: -5.37 Med: 0.7 Max: 11.4
Current: 0.69

During the past 13 years, the highest Debt-to-Equity Ratio of Rockwell Medical was 11.40. The lowest was -5.37. And the median was 0.70.

FRA:RWMA's Debt-to-Equity is ranked worse than
76.18% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs FRA:RWMA: 0.69

Rockwell Medical Debt-to-Equity Historical Data

The historical data trend for Rockwell Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Debt-to-Equity Chart

Rockwell Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.20

0.70

11.40

1.16

0.63

Rockwell Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															1.23	1.68	0.69	0.63	0.69

Competitive Comparison of Rockwell Medical's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rockwell Medical's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Debt-to-Equity falls into.

Rockwell Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Rockwell Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.002	+	10.322)	/	19.524
	=	0.63

Rockwell Medical's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.868	+	11.181)	/	18.992
	=	0.69

Rockwell Medical (FRA:RWMA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Rockwell Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Rockwell Medical (FRA:RWMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (FRA:RWMA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

RMTI:USA

Address

30142 S. Wixom Road, Wixom, MI, USA, 48393

Website

https://www.rockwellmed.com

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.

Rockwell Medical (FRA:RWMA) Headlines

No Headlines